Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001753926-21-000445
Filing Date
2021-09-16
Accepted
2021-09-16 17:16:36
Documents
21

Document Format Files

Seq Description Document Type Size
1 F-1/A g082332_f1a.htm F-1/A 2478727
2 EXHIBIT 1.1 g082332_ex1-1.htm EX-1.1 219028
3 EXHIBIT 4.1 g082332_ex4-1.htm EX-4.1 105593
4 EXHIBIT 4.2 g082332_ex4-2.htm EX-4.2 104970
5 EXHIBIT 4.3 g082332_ex4-3.htm EX-4.3 85958
6 EXHIBIT 4.4 g082332_ex4-4.htm EX-4.4 113557
7 EXHIBIT 5.1 g082332_ex5-1.htm EX-5.1 13713
8 EXHIBIT 5.2 g082332_ex5-2.htm EX-5.2 11134
9 EXHIBIT 10.2 g082332_ex10-2.htm EX-10.2 103457
10 EXHIBIT 10.14 g082332_ex10-14.htm EX-10.14 124321
11 EXHIBIT 10.15 g082332_ex10-15.htm EX-10.5 47459
12 EXHIBIT 23.1 g082332_ex23-1.htm EX-23.1 4046
13 GRAPHIC ex991001.jpg GRAPHIC 11873
14 GRAPHIC ex991002.jpg GRAPHIC 12815
15 GRAPHIC ex991003.jpg GRAPHIC 9405
16 GRAPHIC ex991004.jpg GRAPHIC 800
17 GRAPHIC g082332_img1.jpg GRAPHIC 21498
18 GRAPHIC g082332_img2.jpg GRAPHIC 52191
19 GRAPHIC g082332_img3.jpg GRAPHIC 97049
20 GRAPHIC g082332_img4.jpg GRAPHIC 29155
21 GRAPHIC img001_v4.jpg GRAPHIC 5020
  Complete submission text file 0001753926-21-000445.txt   3744110
Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5
Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621
XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-258741 | Film No.: 211258637
SIC: 2834 Pharmaceutical Preparations